The goal of this workshop was to examine the types of evidence being collected as part of genomics-based programs at health care systems, consider near-term opportunities for advancing knowledge about ...
If you have ever welcomed a new baby into the world, you know the mix of hope and uncertainty that comes with those first days. For decades, newborn screening has been a quiet triumph of public health ...
Adding genomic sequencing to newborn blood screening would detect hundreds of additional childhood conditions, providing much earlier diagnosis and treatment, according to a new study. A baby's genome ...
‘BEACONS,’ a multi-state collaboration led by Mass General Brigham and Ariadne Labs, will enroll up to 30,000 newborns to explore adding genomic sequencing in U.S. newborn screening GAITHERSBURG, Md.- ...
Genetic conditions with actionable interventions affect nearly 10% of populations in the United States and internationally - ...
More than a decade ago, researchers launched the BabySeq Project, a pilot program to return newborn genomic sequencing results to parents and measure the effects on newborn care. Today, over 30 ...
In Destiny’s Child No Longer: Rewriting Genetic Fate, we envisioned a world where every newborn would be screened for genetic risks. We see a future in which the randomness of genetic inheritance ...
Family health history "gold standard" at assessing disease risk, experts say. Nov. 5, 2010— -- The widely held belief that you can always rely on family may be especially true when it comes to ...
Leading genomic health experts from Monash University are calling for urgent government funding to progress the development of a national preventive genomic testing program that would save thousands ...
Data to be presented at the International Conference on Newborn Sequencing (ICoNS) highlighting lessons learned from the GUARDIAN and Early Check newborn sequencing studies showcasing GeneDx’s deep ...
Data from more than 22,000 newborns reinforce GeneDx’s role spearheading the adoption of genomic newborn screening (gNBS) from research to clinical practice GeneDx (Nasdaq: WGS), a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback